Asian Oncol Nurs.  2019 Dec;19(4):252-261. 10.5388/aon.2019.19.4.252.

Status and Strategies for Safety Management of Antineoplastic Drugs among Oncology Nurses

• Park JY
• Noh GO
• Kwon IG

• KMID: 2467640
• DOI: http://doi.org/10.5388/aon.2019.19.4.252

Abstract

PURPOSE
The purpose of this study was to identify the work environment related to the handling and administration of antineoplastic drugs in the members of the Korean Oncology Nursing Society.
METHODS
The study was carried out from October 2018 to November 2018. The self-reported surveys included questions on the work environment, experience and concerns from occupational exposure, safe activities of antineoplastic drugs and use of personal protective equipment (PPE), hand hygiene, and type of PPE (e.g., gown, gloves, and mask).
RESULTS
A total of 125 participants from 41 organizations were surveyed. The nurses were mostly educated on safe management of antineoplastic drugs (95.2%) and concerned about health threats caused by occupational exposure (7.23±2.14 out of 10). In addition, harmful activities were found, with gown use being the lowest when handling antineoplastic drugs.
CONCLUSION
This study supports that appropriate staffing, equipment, and facilities, mandatory education, and establishment of policies are very important in creating a safe work environment for handling antineoplastic drugs.

Keyword

Safety; Personal protective equipment; Occupational exposure; Antineoplastic agents; Nurses

MeSH Terms

Antineoplastic Agents*
Education
Hand Hygiene
Occupational Exposure
Oncology Nursing
Personal Protective Equipment
Safety Management*
Antineoplastic Agents

Reference

1. Fransman W, Roeleveld N, Peelen S, de Kort W, Kromhout H, Heederik D. Nurses with dermal exposure to antineoplastic drugs: reproductive outcomes. Epidemiology. 2007; 18:112–119.

2. National Institute for Occupational Safety and Health (NIOSH). NIOSH list of antineoplastic and other hazardous drugs in healthcare settings 2012 [Internet]. Accessed October 4, 2019. Available from: https://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf.

3. Kim BK, Lee SL, Youn JH, Kim SM, Kim MH. Nurses' knowledge, compliance and exposure experiences with cytotoxic drugs in a university hospital. Glob Health Nurs. 2016; 6:11–19.

4. Korean Oncology Nursing Society. Safe handling guideline of cytotoxic drugs: chemotherapy. J Korean Oncol Nurs. 2008; 8:178–190.

5. Park JY, Kawk M, Park H, Song SK, Yun J, Cho HJ, et al. Korean oncology nursing society guidelines on oral chemotherapy. Asian Oncol Nurs. 2017; 17:201–212.

6. Neuss MN, Gilmore TR, Belderson KM, Billett AL, Conti-Kalchik T, Harvet BE, et al. Updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards, including standards for pediatric oncology. Oncol Nurs Forum. 2017; 44:31–43.

7. American Society of Hospital Pharmacists. ASHP guidelines on handling hazardous drugs. Am J Health Syst Pharm. 2006; 63:1172–1193.

8. Yun JH, Park JY. Oncology nurses' knowledge of safety guidelines and compliance with safe handling of antineoplastic agent in a tertiary hospital. Asian Oncol Nurs. 2016; 16:251–260.

9. Polovich M, Martin S. Nurses' use of hazardous drug-handling precautions and awareness of national safety guidelines. Oncol Nurs Forum. 2011; 38:718–726.

10. Kim SM, Hong SO, Chung HS, Park JY. Safe handling of cytotoxic drugs and use of personal protective equipment among nurses at a regional cancer center. Asian Oncol Nurs. 2018; 18:206–213.

11. Chang SJ, Lee HO, Kwon JH, Lee SH. The effects of safe handling education of antineoplastic drug on knowledge and performance of clinical nurses. J Korean Clin Nurs Res. 2016; 22:217–224.

12. Jeong KW, Lee BY, Kwon MS, Jang JH. Safety management status among nurses handling anticancer drugs: nurse awareness and performance following safety regulations. Asian Pac J Cancer Prev. 2015; 16:3203–3211.

13. Jung JY, Park JY. Factors influencing compliance with safety guidelines of anticancer drugs among nurses in general hospitals. Asian Oncol Nurs. 2019; 19:106–113.

14. Callahan A, Ames NJ, Manning ML, Touchton-Leonard K, Yang L, Wallen R. Factors influencing nurses' use of hazardous drug safe handling precautions. Oncol Nurs Forum. 2016; 43:342–349.

15. Kim O, Lee H, Jung H, Jang HJ, Pang Y, Cheong H. Korean nurses' adherence to safety guidelines for chemotherapy administration. Eur J Oncol Nurs. 2019; 40:98–103.

16. Park IS. An analysis on metropolitan concentration factors of health care utilization in local cancer patients using GWR. J Community Welf. 2016; 56:29–56.

17. Park SJ, Kim HJ. Nurses' compliance with safety guidelines for the use of antineoplastic agents, observable symptoms, and stress from occupational exposure. J Korean Acad Fundam Nurs. 2018; 25:293–300.

18. Kumari S, Lobo DJ, Sequira L. Potential health risks among oncology staff nurses of selected hospitals due to antineoplastic drug exposure. Indian J Public Health Res Dev. 2017; 8:358–361.

19. Nixon S, Schulmeister L. Safe handling of hazardous drugs: are you protected? Clin J Oncol Nurs. 2009; 13:433–439.

20. Klos D, Riško J, Stašek M, Loveček M, Hanuliak J, Skalický P, et al. Current status of cytoreductive surgery (CRS) and intraperitoneal hyperthermic chemotherapy (HIPEC) in the multimodal treatment of peritoneal surface malignancies. Cas Lek Cesk. 2018; 157:419–428.